DrugInfoSys

Tetracosactrin

Also known as: Tetracosactide, Cosyntropin

Drug #705

Tetracosactrin is a synthetic polypeptide. Tetracosactrin is used as a test of adrenal function and for the treatment of inflammatory or degenerative disorders.

Primary Characteristics

Tetracosactrin is also known as Tetracosactide, Cosyntropin.

It is of Synthetic origin and belongs to Polypeptide.

It belongs to ACTH agonist pharmacological group on the basis of mechanism of action. It is also classified under Diagnostic Aids .

Molecular Weight: 2993.5 · Solubility in Water: 1 in 70 · Solubility in Alcohol: insoluble · Non-proprietary name: Tetracosactrin.

Molecular structure of Tetracosactrin

Pharmacokinetics

Absorption: Tetracosactrin has an oral bioavailability is 0.5% (±0.5%).

Distribution: Tetracosactrin has a volume of distribution is 0.4 l/kg.

Elimination: plasma half-life is 3 hr, renal excretion is 95 - 100 %.

Advertisement

Indications

Contraindications

Tetracosactrin is contraindicated in conditions like Asthma, Cushing's syndrome, Heart failure, Peptic ulcer, Psychosis, Infections, Hypersensitivity.

Dosage

Tetracosactrin's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
3.57 ug/kg3.57 ug/kgIM For Once or As Required
Paediatric Dosage (20kg)
25 ug/kg25 ug/kgIntra Muscular Single Dose
25 ug/kg25 ug/kgIntra Venous Single Dose
Neonatal Dosage (3kg)
36 ug/kg36 ug/kgIntramuscularSingle dose

Drug Interactions

None recorded.

Side Effects

Tetracosactrin in overdosage may give rise to further complications which include Osteoporosis , Diabetes , Growth retardation , Hypertension .

Tetracosactrin produces potentially life-threatening effects which include Anaphylaxis . Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Tetracosactrin are Hyperglycemia.

Tetracosactrin is known to cause more or less tolerable side effects which are usually transient. These include Acne, Bruising, Hirsutism , Menstrual irregularity, Pain , Skin atrophy.

Warnings / Precautions

Avoid tetracosactrin in patients with history of allergic disorder such as asthma. Self administration is not recommended.

Interference in Pathology

Tetracosactrin may interfere in the diagnosis of Radioimmunoassay of endogeous ACTH .

Available Brands

None recorded.

Storage Conditions

Tetracosactrin should be stored IV Inj, IM Inj.

Drug Classification

  1. 1.18.9ACTH